ÐÇ¿ÕÓéÀÖ¹ÙÍø- BRFSS – ACBS 2023 Adult Prevalence Table 5
State/Territory | Current | |||
---|---|---|---|---|
Sample size± |
% | SE§ | 95% CI† | |
Arizona | 397 | 9.1 | 2.4 | (4.4 – 13.8) |
California | 300 | 10.8 | 2.8 | (5.3 – 16.3) |
Connecticut | 467 | 5.4 | 1.3 | (2.9 – 7.9) |
Florida | 390 | N/A | N/A | (N/A – N/A) |
Georgia | 285 | 7.6 | 2.2 | (3.3 – 11.9) |
Hawaii | 200 | 10.9 | 3.0 | (5.0 – 16.8) |
Indiana | 544 | 6.9 | 1.4 | (4.2 – 9.6) |
Iowa | 296 | N/A | N/A | (N/A – N/A) |
Kansas | 259 | 13.0 | 2.6 | (7.9 – 18.1) |
Kentucky | 228 | 8.8 | 2.6 | (3.7 – 13.9) |
Maine | 401 | 6.4 | 1.8 | (2.9 – 9.9) |
Massachusetts | 254 | N/A | N/A | (N/A – N/A) |
Michigan | 523 | 5.5 | 1.2 | (3.1 – 7.9) |
Minnesota | 465 | 8.7 | 2.3 | (4.2 – 13.2) |
Missouri | 208 | 6.1 | 1.7 | (2.8 – 9.4) |
Montana | 178 | N/A | N/A | (N/A – N/A) |
Nebraska | 365 | 8.5 | 2.0 | (4.6 – 12.4) |
New Hampshire | 389 | 6.1 | 1.6 | (3.0 – 9.2) |
New Jersey | 305 | 5.3 | 1.3 | (2.8 – 7.8) |
New York | 280 | 7.7 | 2.2 | (3.4 – 12.0) |
Ohio | 389 | 11.0 | 2.8 | (5.5 – 16.5) |
Rhode Island | 247 | 11.0 | 2.9 | (5.3 – 16.7) |
Texas | 204 | N/A | N/A | (N/A – N/A) |
Utah | 438 | 5.7 | 1.2 | (3.3 – 8.1) |
Vermont | 470 | 5.8 | 1.2 | (3.4 – 8.2) |
Wisconsin | 427 | 5.7 | 1.2 | (3.3 – 8.1) |
Puerto Rico | 288 | 6.8 | 1.7 | (3.5 – 10.1) |
27 States / Area | 9,197 | 7.9 | 0.7 | (6.5 – 9.3) |
Median | 7.3 | |||
Range | 5.3-13.0 |
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30
Link for Summary Data Quality Report: /brfss/acbs/2023/pdf/sdq_report_acbs_23-508.pdf